| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 02/26/2009 | US20090054652 Cyanine Compound and Optical Recording Material |
| 02/26/2009 | US20090054650 Novel Catalysts Useful for Catalyzing the Coupling of Arylhalides with Arylboronic Acids |
| 02/26/2009 | US20090054643 Novel method of synthesis of fluoroquinolones |
| 02/26/2009 | US20090054477 4-thio substituted quinoline and naphthyridine compounds |
| 02/26/2009 | US20090054448 Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors |
| 02/26/2009 | US20090054445 Amide Substituted Quinolines |
| 02/26/2009 | US20090054440 Quinoline derivatives as neurokinin receptor antagonists |
| 02/26/2009 | US20090054420 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 02/26/2009 | US20090054402 7-substituted indole mcl-1 inhibitors |
| 02/26/2009 | US20090054235 Benzoheterocyclylethylbenzamide derivatives |
| 02/26/2009 | US20090053641 Charge control agent and related art |
| 02/26/2009 | US20090053236 USE OF COMBINATION OF ANTI-ANGIOGENIC SUBSTANCE AND c-kit KINASE INHIBITOR |
| 02/26/2009 | CA2697284A1 Therapeutic quinoline and naphthalene derivatives |
| 02/26/2009 | CA2695845A1 Transition metal complex and process for producing conjugated aromatic compound using the transition metal complex |
| 02/26/2009 | CA2691450A1 4-benzylaminoquinolines, pharmaceutical compositions containing them, and their use in therapy |
| 02/25/2009 | EP2027094A2 Method of preparing 4-halogenated quinoline intermediates |
| 02/25/2009 | EP1701934B1 DISUBSTITUTED CHALCONE OXIMES HAVING RAR(Gamma)-RETINOID RECEPTOR ANTAGONIST ACTIVITY |
| 02/25/2009 | EP1578726B1 Tetrahydroquinoline derivatives |
| 02/25/2009 | EP1506188B1 Process for the preparation of a hydrate of an anthranilic acid derivative |
| 02/25/2009 | EP1015445B1 Antimicrobial quinolones, their compositions and uses |
| 02/25/2009 | CN101374849A Quinoline-4-ketones derivates as ABC transport protein regulation/control agent |
| 02/25/2009 | CN101372475A Aromatic heterocyclic substituted acardite derivative and use thereof |
| 02/24/2009 | US7495104 Quinoline or quinazoline derivatives inhibiting auto-phosphorylation of fibroblast growth factor receptors |
| 02/24/2009 | US7495103 including cystic fibrosis transmembrane conductance regulator ("CFTR"), used for treating genetic disorders; respiratory system disorders |
| 02/24/2009 | US7495022 α,β-unsaturated hydroxamic acid derivatives and their use as histone deacetylase inhibitors |
| 02/24/2009 | US7495012 Arylsulfonamides and uses related thereto |
| 02/19/2009 | WO2008130600A3 Quinolones and azaquinolones that inhibit prolyl hydroxylase |
| 02/19/2009 | US20090048295 Substituted 5,6,7,8-tetrahydroquinoline derivatives, compositions, and methods of use thereof |
| 02/19/2009 | US20090048294 Hif-1 alpha activating agent |
| 02/19/2009 | US20090048276 Inhibitors of Fatty Acid Synthase (Fas) |
| 02/19/2009 | US20090048255 Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs |
| 02/19/2009 | US20090048228 Heterocycle Derivatives As Histone Deacetylase (Hdac) Inhibitors |
| 02/19/2009 | US20090048226 Inhibitors of caspases |
| 02/19/2009 | US20090048224 Compounds and methods of use |
| 02/18/2009 | EP2024341A2 Novel process for statins and its pharmaceutically acceptable salts thereof |
| 02/18/2009 | EP2024333A2 Amino-ethyl-amino-aryl (aeaa) compounds and their use |
| 02/18/2009 | EP1928833B1 Novel quinoline compounds capable of binding at the cb2 receptor |
| 02/18/2009 | EP1831172B1 Substituted carbamic acid quinolin-6-yl esters useful as acetylcholinesterase inhibitors |
| 02/18/2009 | EP1399431B1 Novel nitriles useful as reversible inhibitors of cysteine proteases |
| 02/18/2009 | CN101370782A Alkylsulphonamide quinolines |
| 02/18/2009 | CN101370781A Novel quinoline compound, and composition containing centipede extract or compounds isolated therefrom for prevention and treatment of cardiovascular disease |
| 02/18/2009 | CN101370780A Organic compound |
| 02/18/2009 | CN101367762A Preparation method of midbody 7-chloroquinaldine |
| 02/18/2009 | CN101367761A 6,7- substituted-2,2,4-trimethyl-tetrahydroquinoline-1-carboxylic acid aryl amide, synthesis and uses thereof |
| 02/18/2009 | CN101366714A Acetylene derivatives having mGluR5 antagonistic activity |
| 02/18/2009 | CN100462358C Aluminum chelate complex for organic EL material |
| 02/18/2009 | CN100462357C Preparing method of 8-bromo-5,6-difluoro-2-methylquinoline |
| 02/17/2009 | US7491827 Aryl sulfonamides useful as inhibitors of chemokine receptor activity |
| 02/17/2009 | US7491825 e.g. N-[2-[4-(2-(S)-amino-6-dimethylamino-hexanoyl)-piperazin-1-yl]-1,1-dimethyl-2-oxo-ethyl]-2,4-dichloro-3-(2-methyl -quinolin-8-yloxy-methyl)-benzensulfonamide trifluoroacetate; antiinflammatory agent; asthma, chronic bronchitis, allergic rhinitis, obstructive pulmonary disease (COPD) |
| 02/17/2009 | US7491747 4-(Arylthio)- or (4-heteroarylthio)butyric acid derivatives that may be used in the treatment of dyslipidaemia, atherosclerosis and diabetes |
| 02/17/2009 | US7491741 Diaminopropionic acid derivatives |
| 02/17/2009 | US7491739 TNF-α production inhibitors |
| 02/17/2009 | US7491733 Bicyclic guanidine derivatives and therapeutic uses thereof |
| 02/17/2009 | US7491726 Characterized by x-ray powder diffraction pattern having peaks expressed as 2 theta at 8.7, 11.6, 16.3, 17.7, 18.6, 20.3, 23.4, 24.9 degrees; stable and reproducible; preparation via crystalline forms of aripiprazole hydrochloride serves as a means of producing pure aripiprazole |
| 02/17/2009 | US7491723 Alkanol and cycloalkanol-amine derivatives and methods of their use |
| 02/12/2009 | WO2009020140A1 Adamantylurea derivative |
| 02/12/2009 | WO2008121817A3 Quinoline derivatives and pharmaceutical compositions comprising them for selectin inhibition |
| 02/12/2009 | US20090043094 Process for trans-4-amino-1-cyclohexanecarboxylic acid derivatives |
| 02/12/2009 | US20090042934 Sulfonyl-Quinoline Derivatives |
| 02/12/2009 | US20090042933 Derivatives of 4-(2-amino -1-hydroxyethyl)phenol as agonists of the Beta2 adrenergic receptor |
| 02/12/2009 | US20090042881 Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 02/12/2009 | US20090042875 Substituted heterocyclic compounds and uses thereof |
| 02/12/2009 | US20090042862 Novel compounds |
| 02/12/2009 | US20090042842 Analogues of cilostazol |
| 02/12/2009 | US20090042820 Tubulin Binding Anti Cancer Agents And Prodrugs Thereof |
| 02/12/2009 | US20090042819 Organic nitric oxide donor salts of antimicrobial compounds, compositions and methods of use |
| 02/12/2009 | US20090041675 Organic compounds |
| 02/11/2009 | EP2021333A2 Anti-proliferative compounds deriving from a 3-aryl-coumarine or 3-aryl-quinolin-2-one and uses thereof |
| 02/11/2009 | CN101365683A Process for making montelukast and intermediates therefor |
| 02/11/2009 | CN101365677A Compounds for the treatment of inflammatory disorders and microbial diseases |
| 02/11/2009 | CN101362719A Chinolines derivates and composition containing thereof |
| 02/10/2009 | US7488823 4-anilino quinazolines substituted with a N'-cyanoguanidinoalkyl group; antiproliferative, anticancer, antiinflammatory |
| 02/10/2009 | US7488740 Substituted quinolin-4-ylamine analogues |
| 02/10/2009 | US7488739 platelet aggregation inhibitors; anti-platelet agent with a high safety profile with a smaller adverse bleeding effect; P2Y12 inhibitor; (2S)-2-({[7-(cyclohexylamino)-1-cyclopentyl-6-fluoro-4-oxo-1,4-dihydroquinolin-3-yl]carbonyl}amino)butanedioic acid |
| 02/05/2009 | WO2009016812A1 Prophylactic and/or therapeutic agent for anemia comprising 2-phenylquinoline-4-carboxylic acid derivative as active ingredient |
| 02/05/2009 | WO2009016191A1 Process for preparing a leukotriene antagonist and an intermediate thereof |
| 02/05/2009 | US20090036684 Method for producing 4-oxoquinoline compound |
| 02/05/2009 | US20090036682 Crystalline form of 8-(4-Methyl-piperazin-1-yl)-3-phenylsulfonylquinoline; used in the treatment of CNS and other disorders |
| 02/05/2009 | US20090036457 Utilities of olefin derivatives |
| 02/05/2009 | US20090033210 Compound and organic light emitting device |
| 02/04/2009 | EP2019825A1 Inhibitors of human immunodeficiency virus replication |
| 02/04/2009 | EP2019674A2 Histone deacetylase and tubulin deacetylase inhibitors |
| 02/04/2009 | EP1824817B1 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists |
| 02/04/2009 | CN101360738A Compositions and methods for modulating gated ion channels |
| 02/04/2009 | CN101357902A Method for preparing N- formyl-2H-4chloroquinoline derivate |
| 02/04/2009 | CN100457737C Quinolyl amide derivative and its preparation process and use |
| 02/04/2009 | CN100457726C Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obestity and type II diabetes |
| 02/03/2009 | US7485643 Bicyclic inhibitors of MEK and methods of use thereof |
| 01/29/2009 | WO2009013885A1 Inhibitor of the differentiation of t cells into th1 cells |
| 01/29/2009 | WO2009013354A1 ARYLMETHYLENE SUBSTITUTED N-ACYL-β-AMINO ALCOHOLS |
| 01/29/2009 | WO2009013163A1 Use of metal complex compounds as oxidation catalysts |
| 01/29/2009 | WO2008146156A3 An improved process for the preparation of aripiprazole |
| 01/29/2009 | WO2008060269A3 Quinoline methanol compounds for the treatment and prevention of parasitic infections |
| 01/29/2009 | US20090030197 Quinoline Intermediates of Receptor Tyrosine Kinase Inhibitors and the Synthesis Thereof |
| 01/29/2009 | US20090030038 Novel 8-Sulfonylamino-3 Aminosubstituted Chroman or Tetrahydronaphtalene Derivatives Modulating the 5Ht6 Receptor |
| 01/29/2009 | US20090029991 Benzamide derivatives useful as histone deacetylase inhibitors |
| 01/29/2009 | US20090029987 Pharmaceutical Compositions for the Prevention and Treatment of Complex Diseases and Their Delivery by Insertable Medical Devices |
| 01/29/2009 | US20090029965 Vasopressin V1a Antagonists |
| 01/29/2009 | US20090029958 Phenethanolamine derivatives as beta2 adrenoreceptor agonists |
| 01/29/2009 | US20090029855 Quinoline Derivatives and Their Use as Pesticides |